Your email has been successfully added to our mailing list.

×
0 0 0.0173913043478262 0 0 0.0260869565217392 0.0608521739130435 -0.0626086956521738
Stock impact report

RedHill Bio doses first COVID-19 patient with Opaganib in Israel; shares up 9% premarket [Seeking Alpha]

Redhill Biopharma Ltd. - American Depositary Shares (RDHL) 
US:NASDAQ Investor Relations: ir.redhillbio.com/investor-relations
Company Research Source: Seeking Alpha
RedHill Biopharma (NASDAQ:RDHLdosedThe treatment is administered under a compassionate use program in accordance with the Israeli Ministry of Health guidelines, with additional patients expected to be treated in coming days.RedHill is also preparing for potential ramp-up of manufacturing of opaganib.Shares are up9% Show less Read more
Impact Snapshot
Event Time:
RDHL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for RDHL alerts
Opt-in for
RDHL alerts

from News Quantified
Opt-in for
RDHL alerts

from News Quantified